Cullinan Therapeutics, Inc.
CGEM- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789972
In the last 90 days, Cullinan Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 183 institutions reported holding it in 13F filings for Q2 2026, worth $1.30B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Cullinan Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 75 | 82 | +7 |
| Shares | 36.4M | 36.9M | +488.4K (+1.3%) |
| Value | $559.7M | $386.3M | −$173.4M (−31.0%) |
New holders (12)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parametric Portfolio Associates LLC | 65,443 | $685.0K | 0.00% |
| HRT Financial LP | 14,180 | $148.0K | 0.00% |
| DuPont Capital Management Corp | 11,348 | $119.0K | 0.00% |
| Millennium Management LLC | 10,515 | $110.0K | 0.00% |
| Barclays PLC | 7,328 | $77.0K | 0.00% |
| Leonteq Securities AG | 4,000 | $41.9K | 0.00% |
| Amalgamated Bank | 3,207 | $34.0K | 0.00% |
| Amalgamated Financial Corp. | 3,207 | $34.0K | 0.00% |
| Prospera Financial Services Inc | 1,168 | $12.0K | 0.00% |
| Lindbrook Capital, LLC | 145 | $2.00K | 0.00% |
| Group One Trading, L.P. | 100 | $1.00K | 0.00% |
| Parallel Advisors, LLC | 6 | $0 | 0.00% |
Sold out (5)
Institutions that held Cullinan Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Renaissance Technologies LLC | 26,600 | $410.0K |
| ProShare Advisors LLC | 11,810 | $183.0K |
| SG Americas Securities, LLC | 10,916 | $168.0K |
| Dark Forest Capital Management LP | 10,214 | $158.0K |
| Point72 Hong Kong Ltd | 929 | $14.0K |